康緣藥業(600557.SH):董事、副總經理、董祕兼財務總監尹洪剛辭職
格隆匯10月10日丨康緣藥業(600557.SH)公佈,公司董事會近日收到董事、副總經理、董事會祕書兼財務總監尹洪剛遞交的辭職報吿,尹洪剛因個人原因申請辭去上述所有職務,辭任後將不在公司擔任任何職務。尹洪剛的辭職不會影響公司日常經營的正常運作,辭職報吿於送達董事會之日起生效。
根據《上海證券交易所股票上市規則》的相關規定,在公司未正式聘任新的董事會祕書之前,暫由公司董事長肖偉代行董事會祕書職責,公司董事會將按照相關規定儘快聘請新的董事會祕書。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.